FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Frost Ronald 		2. Issuer Name and Ticker or Trading Symbol

MERIT MEDICAL SYSTEMS INC [ MMSI ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
Chief Operating Officer
(Last)          (First)          (Middle)

1600 WEST MERIT PARKWAY 		3. Date of Earliest Transaction (MM/DD/YYYY)

7/30/2019
(Street)

SOUTH JORDAN, UT 84095
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, No Par Value                  16311   I   By 401(k) plan   (1)
Common Stock   7/30/2019     P    5000   A $40   5000   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-qualified stock options (right to buy)   $12.06                    10/4/2015   (2) 10/4/2021   Common Stock   25000.0     25000   D    
Non-qualified stock options (right to buy)   $17.27                    2/13/2016   (3) 2/13/2022   Common Stock   20000.0     20000   D    
Non-qualified stock options (right to buy)   $16.05                    1/28/2017   (4) 1/28/2023   Common Stock   20000.0     20000   D    
Non-qualified stock options (right to buy)   $28.2                    4/14/2018   (5) 4/14/2024   Common Stock   50000.0     50000   D    
Non-qualified stock options (right to buy)   $44.8                    3/2/2019   (6) 3/2/2025   Common Stock   40000.0     40000   D    
Non-qualified stock options (right to buy)   $55.73                    3/1/2020   (7) 3/1/2026   Common Stock   30000.0     30000   D    

Explanation of Responses:
(1)  Represents plan holdings as of 07/30/2019.
(2)  Become exercisable in equal annual installments of 20% commencing 10/04/2015.
(3)  Become exercisable in equal annual installments of 20% commencing 02/13/2016.
(4)  Become exercisable in equal annual installments of 20% commencing 01/28/2017.
(5)  Become exercisable in equal annual installments of 20% commencing 04/14/2018.
(6)  Becomes exercisable in equal annual installments of 20% commencing 03/02/2019.
(7)  Becomes exercisable in equal annual installments of 20% commencing 03/01/2020.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Frost Ronald
1600 WEST MERIT PARKWAY
SOUTH JORDAN, UT 84095

Chief Operating Officer

Signatures
Brian G. Lloyd, Attorney-in-Fact 7/31/2019
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Merit Medical Systems (NASDAQ:MMSI)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Merit Medical Systems Charts.
Merit Medical Systems (NASDAQ:MMSI)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Merit Medical Systems Charts.